Product Code: ETC5359017 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The Israel Buprenorphine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Although the growth rate starts strong at 8.08% in 2025, it steadily loses momentum, ending at 8.01% by 2029.
In the Europe region, the Buprenorphine market in Israel is projected to expand at a growing growth rate of 6.72% by 2027. The largest economy is Germany, followed by United Kingdom, France, Italy and Russia.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Buprenorphine Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Buprenorphine Market - Industry Life Cycle |
3.4 Israel Buprenorphine Market - Porter's Five Forces |
3.5 Israel Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Israel Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Israel Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of buprenorphine therapy in managing opioid addiction. |
4.2.2 Growing government initiatives to combat opioid abuse and enhance access to opioid addiction treatment. |
4.2.3 Rising prevalence of opioid addiction cases in Israel leading to higher demand for buprenorphine products. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for prescribing and dispensing buprenorphine products. |
4.3.2 Limited reimbursement policies for buprenorphine therapy in Israel. |
5 Israel Buprenorphine Market Trends |
6 Israel Buprenorphine Market Segmentations |
6.1 Israel Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Israel Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 Israel Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Israel Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Israel Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Israel Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Israel Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Israel Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Israel Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Israel Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Israel Buprenorphine Market Import-Export Trade Statistics |
7.1 Israel Buprenorphine Market Export to Major Countries |
7.2 Israel Buprenorphine Market Imports from Major Countries |
8 Israel Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in buprenorphine therapy. |
8.2 Rate of adoption of buprenorphine therapy among opioid addiction patients. |
8.3 Patient retention rates in buprenorphine treatment programs. |
9 Israel Buprenorphine Market - Opportunity Assessment |
9.1 Israel Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Israel Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Israel Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Buprenorphine Market - Competitive Landscape |
10.1 Israel Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Israel Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |